These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38247149)

  • 1. Letter: Prioritising osteosarcopenia assessment in the ongoing care of patients with cholestatic liver diseases. Authors' reply.
    Thomson M; Scott A; Trost S; Lake J; Lim N
    Aliment Pharmacol Ther; 2024 Feb; 59(4):585-586. PubMed ID: 38247149
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Prioritising osteosarcopenia assessment in the ongoing care of patients with cholestatic liver diseases.
    Arcari I; Colapietro F; Pugliese N
    Aliment Pharmacol Ther; 2024 Feb; 59(4):583-584. PubMed ID: 38247144
    [No Abstract]   [Full Text] [Related]  

  • 3. Oesophageal and scaly skin lesions associated with chronic cholestatic liver disease.
    Kasper P; Goeser T; Nierhoff D
    Gut; 2019 Nov; 68(11):1960-2018. PubMed ID: 30878948
    [No Abstract]   [Full Text] [Related]  

  • 4. [Management of pruritus in patients with cholestatic liver disease].
    Kremer AE; Kraus MR
    MMW Fortschr Med; 2016 Jun; 158(12):64-7. PubMed ID: 27324009
    [No Abstract]   [Full Text] [Related]  

  • 5. Cholestatic Liver Diseases: A Primer for Generalists and Subspecialists.
    Hilscher MB; Kamath PS; Eaton JE
    Mayo Clin Proc; 2020 Oct; 95(10):2263-2279. PubMed ID: 33012354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers of cholestasis.
    Pieters A; Gijbels E; Cogliati B; Annaert P; Devisscher L; Vinken M
    Biomark Med; 2021 Apr; 15(6):437-454. PubMed ID: 33709780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical management of chronic cholestatic liver diseases.
    Gossard AA; Lindor KD
    Can J Gastroenterol; 2000 Nov; 14 Suppl D():93D-98D. PubMed ID: 11110620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholestatic liver diseases in adults.
    McGill JM; Kwiatkowski AP
    Am J Gastroenterol; 1998 May; 93(5):684-91. PubMed ID: 9625109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholestatic liver disease.
    Jüngst C; Lammert F
    Dig Dis; 2013; 31(1):152-4. PubMed ID: 23797137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholestatic liver diseases.
    Levy C
    Clin Liver Dis; 2013 May; 17(2):xiii-xiv. PubMed ID: 23540508
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cholestatic jaundice, an infrequent initial manifestation of primary amyloidosis].
    Conde Martel A; Suárez Ortega S; Redondo E; Guerra C
    Med Clin (Barc); 1995 Apr; 104(14):557. PubMed ID: 7776740
    [No Abstract]   [Full Text] [Related]  

  • 12. [The serum lipoprotein X (LP-X) test in the diagnosis of cholestatic hepatopathies (preliminary note)].
    Colalongo G; Nubile G; Fiorentini GP; Tabacchi L; Beltrandi E
    Boll Soc Ital Biol Sper; 1974 Sep; 50(18):1440-5. PubMed ID: 4458730
    [No Abstract]   [Full Text] [Related]  

  • 13. Idiopathic hypereosinophilic syndrome presenting as cholestatic liver disease.
    Valente AI; Pinto HC; Ramalho F; Cabrita PF; Catarino C; Serejo F; Baptista A; Saragoça A; Bordalo O; Moura MC
    Eur J Gastroenterol Hepatol; 1997 Aug; 9(8):815-7. PubMed ID: 9282282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The epidemiology of cholestasis in hepatopathies].
    Budillon G
    Ann Ital Med Int; 1993 Oct; 8 Suppl():36S-40S. PubMed ID: 7906951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guidelines on the management of cholestasis liver diseases (2021)].
    Chinese Society of Hepatology, Chinese Medical Association
    Zhonghua Nei Ke Za Zhi; 2021 Dec; 60(12):1075-1087. PubMed ID: 34856682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Guidelines on the management of cholestasis liver diseases (2021)].
    Chinese Society of Hepatology, Chinese Medical Association
    Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):253-263. PubMed ID: 35462480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic cholestatic liver diseases : Differential diagnosis, pathogenesis and current treatment in adults].
    Hohenester S; Beuers U
    Internist (Berl); 2017 Aug; 58(8):805-825. PubMed ID: 28721532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cholestasis assessment by activity of antioxidant enzymes and composition of plasma lipoproteins in patients with liver diseases].
    Loginov AS; Matiushin BN; Chebanov SM; Reshetniak VI
    Ter Arkh; 1998; 70(4):40-2. PubMed ID: 9612901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinico-pathogenetic variants of cholestasis in different liver diseases].
    Ivashkin VT; Ivlev AS; Pliusnin SV; Vasil'ev AP
    Ter Arkh; 1992; 64(2):6-9. PubMed ID: 1509386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis of cholestatic jaundice. Role of factor analysis and principal components].
    Romeder JM; Guille C; Hecht Y; Garçon C; Giard MH
    Pathol Biol (Paris); 1971 Oct; 19(19):871-83. PubMed ID: 4943537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.